Comparison Chart Roche Holding AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:31:30 26/04/2024 BST			5-day change	1st Jan Change
221 ^CHF	+1.01%		-0.50%	-9.61%

04-26	Roche: positive CHMP opinion for Alecensa	CF
04-26	Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ROCHE HOLDING AG	Other Pharmaceuticals	+1.01%	-0.50%	-9.61%	-19.53%	-17.03%	195B